Proteomics Research Industry Shows Exponential Growth Signs in Near Future

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Objectives behind This Study:

 To define, describe, segment, and forecast the global proteomics market by instrumentation technology, reagent, services and software, application, end user, and region.

To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges)

To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

To forecast the size of the proteomics market in five main regions along with their respective key countries (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa)

To profile key players in the global proteomics market and comprehensively analyze their core competencies and market shares

To track and analyze competitive developments such as acquisitions; product launches; expansions; collaborations, partnerships, & agreements; and R&D activities of the leading players in the proteomics market

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@

Recent Developments:

In October 2018, Waters Corporation launched its RenataDX Screening System

In October 2018, Thermo Fisher Scientific, Inc. (US) collaborated with Symphogen (Denmark) under which Symphogen will use the Thermo Scientific Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC/MS/MS) system with its BioPharma Option to create, test, and validate platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures.

In July 2018, Thermo Fisher Scientific, Inc. (US) launched the Quadrupole-Orbitrap Mass Spectrometer

In May 2018, Agilent acquired Advanced Analytical Technologies, Inc. (US). This acquisition enhanced Agilent’s technology base to provide customers with a comprehensive set of solutions for next-generation sequencing workflows.

In May 2018, PerkinElmer acquired Shanghai Spectrum Instruments Co., Ltd. (SSI) (China), one of the leading manufacturers of analytical instruments in China. This will help the firm in building its footprint in China through SSI’s localized leading market position.

Critical questions the report answers:

Where will all these developments take the industry in the long term?
What are the upcoming trends in the proteomics market?
Which segment provides the most opportunity for growth?
Who are the leading vendors operating in this market?
What are the opportunities for new market entrants?

Factors Influencing Global Growth:-

Growth in this market is driven by increasing research activity in the area of personalized medicine and drug discovery, increasing R&D expenditure by the pharmaceutical and biotechnology sector, and rising government funding for proteomics.

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The proteomics market is projected to reach USD 38.7 billion by 2024 from USD 19.5 billion in 2019, at a CAGR of 14.7%.

Geographical Growth Scenario:

North America to dominate the proteomics market during the forecast period

In 2018, North America dominated the global proteomics market, followed by Europe. Increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, rising demand for high-quality research tools for data reproducibility, and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the factors propelling the growth of the market in the region.

Leading Market Players:

 Thermo Fisher Scientific, Inc. (US)
Agilent Technologies, Inc. (US)
GE Healthcare (US)
Bio-Rad Laboratories, Inc. (US)
Danaher Corporation (US)
Luminex Corporation (US) and many more…

Read More Detailed Article@